Translate Bio Inc. Company
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
A spokesperson said Translate Bio and Sanofi aims to put a vaccine into a Phase 1 clinical trial between March 2021 and August 2021.
A spokesperson said Translate Bio and Sanofi aims to put a vaccine into a Phase 1 clinical trial between March 2021 and August 2021.
Technology:
COVID
Industry:
Vaccine/Drug
Headquarters:
United States
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership